A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
News-Medical.Net on MSN2d
Yale scientists develop advanced CRISPR tool to study complex genetic interactionsBut to date this technology - which allows scientists to use a "guide" RNA to modify DNA sequences and evaluate the effects - ...
We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025.
Microglia are brain-resident macrophages playing pivotal roles in CNS development and homeostasis. Yet, the cellular and molecular basis governing microglia maintenance ...
After hours: March 21 at 7:54:03 PM EDT Loading Chart for CRSP ...
Although various methods of trait improvements in crops are available and are being used, clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR/Cas9) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback